Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials
Reviews human randomized trials. Certain higher-quality subgroups did not show a clear mortality benefit.
Read original source ↗Research Desk › Research library › Thymosin alpha-1
Last reviewed 2026-11-09 · Written from the published papers linked below
Scientists have studied thymosin alpha-1 in people. Results depend on the condition being studied, and more reliable trials are still needed for many claims.
Human studies exist
Results depend on the question
Not a one-size-fits-all answer
Scientists have studied thymosin alpha-1 in people. Results depend on the condition being studied, and more reliable trials are still needed for many claims.
Research area: Immune research. Studies focus on immune response & clinical trials.
A 2025 review of sepsis trials reported mixed results across study types. Promising findings in one setting do not prove benefit in another.
Not a one-size-fits-all answer. Results depend on the question. A result in cells or animals does not prove the same thing happens in people, and one small study cannot settle a question.
Scientists have studied thymosin alpha-1 in people. Results depend on the condition being studied, and more reliable trials are still needed for many claims.
Not a one-size-fits-all answer. Results depend on the question.
Human studies exist. A 2025 review of sepsis trials reported mixed results across study types. Promising findings in one setting do not prove benefit in another.
Every study on this page links to its original record on PubMed. The newest papers are also searchable live on the Research Desk home page.
Reviews human randomized trials. Certain higher-quality subgroups did not show a clear mortality benefit.
Read original source ↗Summarizes published human clinical experience and limitations.
Read original source ↗See the newest Thymosin alpha-1 papers live from the research libraries → · Trial registry ↗